Company Overview and News


Add SHPG
to your dashboard

Headline News

Biotech Forum Daily Digest: What Now For Sarepta?

6h seekingalpha
Biotech fell to begin the holiday shortened trading week, continuing a bout of poor performance in the fourth quarter of this year. (143-1)

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q3 2017 Update

14h seekingalpha
Halvorsen's 13F portfolio value increased from $14.85B to $15.44B. The number of positions increased from 53 to 59. (1331-3)

Roche's Two Good-News Scoops May Have a Short Shelf Life - Bloomberg Gadfly

16h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (125-1)

'A pretty low act': Life ring stolen from dangerous WA fishing spot

18h smh.com.au
Rock fishing is a notoriously dangerous sport and the coast off Denmark in WA's Great Southern is infamous for the rough conditions anglers are prepared to brave for a lucky catch. (4-0)

Earnings Growth Make Shire (SHPG) a Sell

19h investorplace
Currently, Shire plc (NASDAQ:SHPG) has a Sell using Louis Navellier's investing system and his Portfolio Grader stock evaluator. SHPG has maintained this ranking for 11 months. (3-0)

4 ROTY Holdings That Could Win At ASH And Beyond

2017-11-20 seekingalpha
I also emphasize catalysts beyond the conference and provide my outlook on the future for each stock. (3-0)

Roche Obtains FDA Approval For Hemophilia A Drug, Time To Push Shire Out

2017-11-20 seekingalpha
FDA approval of Hemlibra puts Roche in good position to potentially take the top spot in the Hemophilia A market. (3-0)

Tracking Tweedy Browne Portfolio - Q3 2017 Update

2017-11-20 seekingalpha
The largest five individual stock positions are Cisco Systems, Berkshire Hathaway, Baidu Inc., Johnson & Johnson, and Alphabet, and they account for ~44% of the portfolio. (558-0)

Tracking John Paulson's Paulson & Company Portfolio - Q3 2017 Update

2017-11-18 seekingalpha
Paulson & Company's largest three positions are the SPDR Gold ETF, Shire plc, and Mylan NV. (1155-8)

Ultragenyx's rhGUS Gets FDA Nod for Rare Genetic Disease

2017-11-17 zacks
Ultragenyx Pharmaceutical Inc. (RARE - Free Report) announced that the FDA has approved its genetic disorder drug, vestronidase alfa or rhGUS, for treatment of children and adults with mucopolysaccharidosis VII (MPS VII, also known as Sly syndrome). It is approved under the trade name, MEPSEVII. (43-0)

Roche's (RHHBY) Hemophilia A Drug Receives FDA Approval

2017-11-17 zacks
Roche Holdings (RHHBY - Free Report) announced that the FDA has approved Hemlibra (emicizumab-kxwh) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children with haemophilia A with factor VIII inhibitors. (70-0)

Sangamo's Powerful Pipeline Drives Significant Upside

2017-11-17 seekingalpha
While there has been a high level of excitement over the past few years with regard to CRISPR gene editing possibilities, some of the previously leading methods for effective genome manipulation and gene therapy have been lost in the mix. Sangamo Therapeutics (SGMO) has a strong proprietary product in their Zinc Finger Nuclease [ZFN] technology for genome modulation. They have recently generated significant buzz surrounding their widely successful quarter, and have laid a strong foundation moving forward. (52-0)

Your Daily Pharma Scoop: Portola Ahead Of Catalysts, AstraZeneca Gets 2 FDA Approvals, GW Pharmaceuticals' Price Target Lowered

2017-11-15 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (1487-9)

Your Daily Pharma Scoop: Portola Ahead Of Catalysts, AstraZeneca Gets Two FDA Approvals, GW Pharmaceuticals' Price Target Lowered

2017-11-15 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (1487-2)

BRIEF-Omega Advisors dissolves share stake in Carrizo Oil & Gas, ups in Shire PLC

2017-11-14 reuters
* Omega Advisors Inc dissolves share stake in Carrizo Oil & Gas Inc - SEC Filing‍​ (4-0)

CUSIP: 82481R106